Farmington, CT – According to filings with the U.S. Securities and Exchange Commission, CytoVeris is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Alan Kersey played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CytoVeris

CytoVeris Inc. is an emerging company formed with the vision to change the paradigm in cancer surgery through the introduction of optical based guided surgical tools. Our technology will assist cancer surgeons to discern between cancer tissue and healthy tissue in real-time during surgery and as a result will increase the probability of successful cancer surgery and outcomes. We use a multi-modal approach, including Raman Spectroscopy, to provide an optical fingerprint of the tissue to the molecular level. The need we serve, and the technology we employ, are ready now for introduction and broad market adoption.

To learn more about CytoVeris, visit http://www.cytoveris.com/

Contact:
Alan Kersey, President and Chief Executive Officer
203-631-1966
akersey@cytoveris.com
https://www.linkedin.com/in/alan-kersey-742b8015/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved